Celebrating 60 years of successful allogeneic transplant at EHA 2017
Liposomal chemotherapy CPX-351: safety profile
Venetoclax combination therapy for relapsed CLL
Treatment for older AML patients - when is an allogeneic transplant suitable?
Ibrutinib treatment and its associated risk factors